title: Quantitative (31)P NMR spectroscopy and (1)H MRI measurements of bone mineral and matrix density differentiate metabolic bone diseases in rat models.
abstract: In this study, bone mineral density (BMD) of normal (CON), ovariectomized (OVX), and partially nephrectomized (NFR) rats was measured by (31)P NMR spectroscopy; bone matrix density was measured by (1)H water- and fat-suppressed projection imaging (WASPI); and the extent of bone mineralization (EBM) was obtained by the ratio of BMD/bone matrix density. The capability of these MR methods to distinguish the bone composition of the CON, OVX, and NFR groups was evaluated against chemical analysis (gravimetry). For cortical bone specimens, BMD of the CON and OVX groups was not significantly different; BMD of the NFR group was 22.1% (by (31)P NMR) and 17.5% (by gravimetry) lower than CON. For trabecular bone specimens, BMD of the OVX group was 40.5% (by (31)P NMR) and 24.6% (by gravimetry) lower than CON; BMD of the NFR group was 26.8% (by (31)P NMR) and 21.5% (by gravimetry) lower than CON. No significant change of cortical bone matrix density between CON and OVX was observed by WASPI or gravimetry; NFR cortical bone matrix density was 10.3% (by WASPI) and 13.9% (by gravimetry) lower than CON. OVX trabecular bone matrix density was 38.0% (by WASPI) and 30.8% (by gravimetry) lower than CON, while no significant change in NFR trabecular bone matrix density was observed by either method. The EBMs of OVX cortical and trabecular specimens were slightly higher than CON but not significantly different from CON. Importantly, EBMs of NFR cortical and trabecular specimens were 12.4% and 26.3% lower than CON by (31)P NMR/WASPI, respectively, and 4.0% and 11.9% lower by gravimetry. Histopathology showed evidence of osteoporosis in the OVX group and severe secondary hyperparathyroidism (renal osteodystrophy) in the NFR group. These results demonstrate that the combined (31)P NMR/WASPI method is capable of discerning the difference in EBM between animals with osteoporosis and those with impaired bone mineralization.
authors.affiliation: Department of Orthopaedic Surgery, Children's Hospital, Boston, MA 02115, USA.
authors.forename: Haihui
authors.initials: H
authors.lastname: Cao
authors.forename: Ara
authors.initials: A
authors.lastname: Nazarian
authors.forename: Jerome L
authors.initials: JL
authors.lastname: Ackerman
authors.forename: Brian D
authors.initials: BD
authors.lastname: Snyder
authors.forename: Andrew E
authors.initials: AE
authors.lastname: Rosenberg
authors.forename: Rosalynn M
authors.initials: RM
authors.lastname: Nazarian
authors.forename: Mirko I
authors.initials: MI
authors.lastname: Hrovat
authors.forename: Guangping
authors.initials: G
authors.lastname: Dai
authors.forename: Dionyssios
authors.initials: D
authors.lastname: Mintzopoulos
authors.forename: Yaotang
authors.initials: Y
authors.lastname: Wu
mesh_terms: D000818:Animals; D015519:Bone Density / Q000502:physiology*; D001851:Bone Diseases, Metabolic / Q000378:metabolism* / Q000473:pathology; D005260:Female; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D010024:Osteoporosis / Q000378:metabolism / Q000473:pathology; D010759:Phosphorus Isotopes; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D010759:Phosphorus Isotopes